Citra-Lock（枸橼酸钠注射液）46.7% Kath-Blocklsg. Ampullen
the effective concentrations
提高了整体通畅率
降低导管相关感染
降低严重出血为隧道的untunneld中心静脉导管（ CVC ）
Citra-Lock除了抗凝血作用提供抗微生物和抗生物膜保护和不具有肝素的副作用。

枸橼酸钠（Citra-Lock）用于血液透析患者具有更加安全、可靠的特性，因此，枸橼酸钠注射液被用于血液透析中有明显出血倾向、凝血功能障碍及使用肝素过敏的透析患者的抗凝。 另外，高浓度枸橼酸钠兼有抗凝血和抗感染的作用，亦被用于静脉留置导管的封管。
Citra-Lock
The safe, easy and effective way to lock every catheter.
Citra-LockTM is trisodium citrate solution for catheter locking available from Renalfarma in following concentrations:
Citra-LockTM 4% 5ml vial
Citra-LockTM 30% 5ml vial
Citra-LockTM 46,7% 5ml vial
CitraFlowTM 4% prefilled syringe 2,5ml
In addition to anti-clotting effect Citra-LockTM provides anti-microbial and anti-biofilm protection and does not have heparin side effects.
Citra-LockTM and Citra-FlowTM are registered as a medical device (Class IIb)
New European Guidelines Catheter Lock Solution
In the June edition of NDTplus the new European recommendation of preventing heamodialysis catheters by ERBP is published.
ERBP ( European Renal Best Practice) is the new guidance body of the European Renal Association-European Dialysis and Transplantation Association (ERA-EDTA).
The ERBP recommends to use Citrate lock of minimal 4% as the catheter lock solution instead of heparin.
'The clinical advantages offered by citrate have been
confirmed in at least two meta-analyses Over
time, progressively lower concentrations of citrate have
been applied (from 46.7% to 4%) with still significantly
better results, even in the latter case, than those obtained with heparin locks1' .
1. Vanholder et al, Diagnosis, prevention and treatment of haemodialysis catheter-related blood stream infections (CRBSI), a position statement of European Renal Best Practice (ERBP). NDTplus June 2010
Citra-Lock 46,7 % Lösung   20 x 5,0 ml

请参照详细资料：
1）：http://www.usmed-online.de/usmed/index.php/de/citra-lock/informationen?showall=1&limitstart=
2）：http://www.120ty.net/bencandy.php?fid=50&aid=16376